May J, Thompson J, Rickard K, White G, Harris J P
Department of Surgery, University of Sydney, NSW, Australia.
J Vasc Surg. 1993 Feb;17(2):408-13. doi: 10.1067/mva.1993.37693.
Isolated limb perfusion with urokinase was used to salvage an acutely ischemic lower limb.
Isolated limb perfusion with urokinase over a 90-minute period was used in the treatment of a 69-year-old female patient with acute ischemia of the left leg after thrombosis of a femoral artery bypass graft. Previous balloon embolectomy and heparin therapy had failed. The flow rate was able to be increased progressively without rise in the line pressure during the course of the perfusion, indicating an increase in capacity of the peripheral arterial bed. Fibrinogen and plasminogen levels in the isolated circulation remained low throughout the perfusion. The concentration of cross-linked fibrin degradation particles (d. dimer) rose progressively in the isolated circulation but remained at normal levels in the systemic circulation during perfusion.
Completion angiography demonstrated clearance of thrombus in the popliteal artery and appearance of arteries not seen on preperfusion films. Clinical improvement paralleled the angiographic appearances, with restoration of limb viability.
We concluded that isolated limb perfusion with use of urokinase is safe and worthy of further investigation.
采用尿激酶进行肢体隔离灌注以挽救急性缺血的下肢。
对一名69岁女性患者进行了90分钟的尿激酶肢体隔离灌注治疗,该患者因股动脉旁路移植血栓形成后出现左腿急性缺血。先前的球囊取栓术和肝素治疗均失败。在灌注过程中,流速能够逐渐增加而管路压力未升高,表明外周动脉床容量增加。在整个灌注过程中,隔离循环中的纤维蛋白原和纤溶酶原水平一直较低。交联纤维蛋白降解颗粒(D - 二聚体)的浓度在隔离循环中逐渐升高,但在灌注期间全身循环中仍保持在正常水平。
灌注完成后的血管造影显示腘动脉血栓清除,且出现了灌注前血管造影未显示的动脉。临床改善与血管造影表现一致,肢体恢复存活。
我们得出结论,使用尿激酶进行肢体隔离灌注是安全的,值得进一步研究。